Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference

Rhea-AI Summary

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology firm, has announced that its President and CEO, Chen Schor, will participate in a panel on Gamma Delta CART-Cells at the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference on April 15, 2021. The panel, moderated by John Newman, Ph.D., will run from 1:00 PM to 1:55 PM ET. Adicet is focused on developing allogeneic gamma delta T cell therapies aimed at treating cancer and enhancing anti-tumor responses through innovative engineering techniques.

MENLO PARK, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer, will be participating in a panel discussion at the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference.

Details of the event are as follows:
Panel:	Gamma Delta CART-Cells, and “Squeezed” T-cells
Date:	Thursday, April 15, 2021
Time:	1:00 – 1:55 PM ET
Format:	Panel moderated by John Newman, Ph.D., Managing Director, Biotechnology Analyst

About Adicet Bio, Inc.
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of "off-the-shelf" gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.

Adicet Bio., Inc.
Investor and Media Contacts
Anne Bowdidge
abowdidge@adicetbio.com

Janhavi Mohite
Stern Investor Relations, Inc.
212-362-1200
janhavi.mohite@sternir.com

FAQ

What event is Adicet Bio participating in on April 15, 2021?

Adicet Bio is participating in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference.

Who will represent Adicet Bio at the Canaccord Genuity conference?

Chen Schor, the President and CEO of Adicet Bio, will represent the company.

What is the focus of Chen Schor's panel discussion?

The panel discussion focuses on Gamma Delta CART-Cells and 'Squeezed' T-cells.

What time is Adicet Bio's panel discussion scheduled?

The panel discussion is scheduled for 1:00 PM to 1:55 PM ET.

What is Adicet Bio's focus in biotechnology?

Adicet Bio focuses on discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases.